Sign Up to like & get
recommendations!
0
Published in 2018 at "Diabetes"
DOI: 10.2337/db18-0788
Abstract: The paucity of human donors limits broadened application of β-cell replacement therapy. Insulin-producing cells derived from human embryonic stem cells (hESCs) have recently been investigated clinically as a feasible surrogate to primary tissue. Herein, we…
read more here.
Keywords:
long term;
posttransplant characterization;
pancreatic endoderm;
hesc derived ... See more keywords